Delivery Order SPE2DB24D2012-SPE2DB25FBWYP
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,136.12 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Journavx 50 mg tablets (30-count packaging). The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a $2,111.64 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Journavx 50 mg tablets (100-count unit dose packaging). This firm fixed-price contract, which is not set-aside and is competitively awarded, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, by the Defense Logistics Agency (DLA) to supply 90 tablets of Jardiance 10 mg medication. This competitively awarded, non-set-aside contract carries a ceiling value of $36,770.17 and is scheduled for completion by September 11, 2025. The award represents a single delivery order under AmerisourceBergen's broader Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,264.90 to AmerisourceBergen Drug Corp on August 5, 2025, with a completion deadline of August 6, 2025. This firm fixed-price delivery order, classified as a child contract under the company's larger indefinite delivery vehicle with DLA Troop Support Medical, represents a competitively awarded, non-set-aside transaction. The award was made to AmerisourceBergen's Corporate Office division, headquartered...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $60,450 to AmerisourceBergen Drug Corp on July 21, 2025, for pharmaceutical products and medical supplies. This firm fixed-price delivery order, which is set to complete by July 22, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award is unclassified as a set-aside procurement, indicating it was competitively...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, valued at $3,634.86, represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle through December 2026. AmerisourceBergen, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $2,473.70 and covers the delivery of Jardiance 10 mg tablets in quantities of 90. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $221,505.20 to AmerisourceBergen Drug Corp on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order, issued under contract 4569318070, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this award. The delivery order represents a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,126.93 to AmerisourceBergen Drug Corp on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, represents a child contract action for pharmaceutical and medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,840.50 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued under contract number 4569286828, represents a child award issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBWYPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for supply of Journavx 50 mg tablets (30-count packaging) valued at $3,048.36. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, which enables the company to distribute a broad range of medications and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The company's extensive federal contract portfolio demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements through firm fixed-price delivery orders of varying values, ranging from modest transactions to substantial orders exceeding $45,000, supporting the military's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/12/25 |